Fig. 2From: Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinomaDevelopment and clinical trials of molecular target and immune checkpoint medicines of HCC from 2007 to 2019. Orange: trials with positive results; blue: trials with negative resultsBack to article page